AIM
ABBV icon

Axiom Investment Management’s AbbVie ABBV Stock Holding History

Axiom Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Buy
+4,695
New +$1.04M 0.78% 36
2022
Q4 		$1.36M Buy
8,386
+1,023
+14% +$157K 3.53% 6
2022
Q3 		$988K Buy
7,363
+23
+0.3% +$3.3K 1.97% 9
2022
Q2 		$1.12M Buy
7,340
+21
+0.3% +$3.21K 3.23% 6
2022
Q1 		$1.19M Sell
7,319
-410
-5% -$59.6K 2.58% 9
2021
Q4 		$1.05M Sell
7,729
-725
-9% -$85.6K 1.01% 21
2021
Q3 		$912K Buy
8,454
+26
+0.3% +$2.97K 0.92% 24
2021
Q2 		$949K Sell
8,428
-4,475
-35% -$504K 0.74% 38
2021
Q1 		$1.4M Buy
12,903
+12,368
+2,312% +$1.32M 1.14% 17
2020
Q4 		$480 Sell
535
-9,065
-94% -$871K 0.44% 54
2020
Q3 		$841K Sell
9,600
-317
-3% -$29.8K 0.95% 29
2020
Q2 		$974K Buy
9,917
+5,286
+114% +$465K 1.29% 23
2020
Q1 		$353K Sell
4,631
-43
-0.9% -$3.66K 0.62% 50
2019
Q4 		$414K Sell
4,674
-13,105
-74% -$1.09M 0.59% 54
2019
Q3 		$1.35M Sell
17,779
-36,521
-67% -$2.5M 1.03% 26
2019
Q2 		$3.96M Buy
54,300
+1,882
+4% +$148K 0.72% 32
2019
Q1 		$4.22M Buy
52,418
+2,959
+6% +$242K 0.8% 28
2018
Q4 		$4.56M Buy
+49,459
New +$4.35M 0.96% 25

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Axiom Investment Management's ABBV Position: Q1 2026 in Review

Axiom Investment Management opened a new position in AbbVie (ABBV) in Q1 2026: 4,695 shares worth $1.02M. The stake represents 0.78% of the portfolio and ranks #36 among its holdings. This is a return to the name: Axiom Investment Management previously reported a position in ABBV as recently as Q4 2022.

Axiom Investment Management first reported a position in ABBV in Q4 2018 and has held it in 18 quarters since. The position peaked at $4.56M in Q4 2018. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Axiom Investment Management held 4,695 shares of AbbVie worth $1.02M as of Q1 2026.
  • AbbVie was a new Axiom Investment Management position in Q1 2026.
  • AbbVie made up 0.78% of Axiom Investment Management's portfolio in Q1 2026, its #36 holding.
  • Axiom Investment Management first reported a position in AbbVie in Q4 2018 and has held it in 18 quarters since.
  • Axiom Investment Management's AbbVie position peaked at $4.56M in Q4 2018.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Axiom Investment Management's 13F filing for Q1 2026, filed 26 May 2026.